GlassScriptPhysician profile
Michael J Chaparro
NPI 1134114432
$5,190.70
in general payments reported to CMS, 2019-2025
21 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $226 · 2021: $1,441 · 2022: $2,317 · 2023: $454 · 2024: $139 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $1,514.54 | 2021-2024 | |
| Ulrich Medical USA, INC. | $1,429.73 | 2019-2022 | |
| Nexus Spine, LLC | $666.86 | 2021-2022 | |
| Kuros Biosciences USA, INC | $371.43 | 2021-2025 | Magnetos |
| Spinesource, INC. | $228.95 | 2022 | |
| Ossdsign USA Incorporated | $169.03 | 2023 | |
| Edwards Lifesciences Corporation | $132.17 | 2020 | |
| Biocomposites INC | $125.00 | 2025 | Stimulan |
| Zimvie INC. | $91.76 | 2023 | |
| Xenix Medical LLC | $91.28 | 2023 | |
| 4web, INC. | $87.33 | 2024 | Spine Truss System |
| Takeda Pharmaceuticals U.S.A., INC. | $61.22 | 2020 | |
| Spine Wave, INC. | $41.52 | 2019 | |
| Abiomed | $37.32 | 2024 | Impella |
| Integrity Implants INC. | $32.24 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $22.58 | 2019 | |
| Kerecis Limited | $18.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Woven Orthopedic Technologies, LLC | $18.50 | 2023 | |
| Arbor Pharmaceuticals, INC. | $18.06 | 2022 | |
| Kls-Martin L.P. | $16.56 | 2022 | |
| Aesculap, INC. | $15.91 | 2023 | Mininav |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chaparro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.